Getein Biotech, Inc (SHA:603387)
China
· Delayed Price · Currency is CNY 8.40
+0.02 (0.24%)
Mar 9, 2026, 3:00 PM CST
Getein Biotech Revenue
Getein Biotech had revenue of 245.00M CNY in the quarter ending September 30, 2025, a decrease of -6.55%. This brings the company's revenue in the last twelve months to 1.04B, down -16.45% year-over-year. In the year 2024, Getein Biotech had annual revenue of 1.16B, down -14.93%.
Revenue (ttm)
1.04B
Revenue Growth
-16.45%
P/S Ratio
4.09
Revenue / Employee
535.52K
Employees
1,947
Market Cap
4.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.16B | -204.36M | -14.93% |
| Dec 31, 2023 | 1.37B | -452.70M | -24.85% |
| Dec 31, 2022 | 1.82B | 420.16M | 29.97% |
| Dec 31, 2021 | 1.40B | 278.37M | 24.78% |
| Dec 31, 2020 | 1.12B | 155.13M | 16.02% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Medlander Medical Technology | 431.59M |
| Ningbo David Medical Device | 516.76M |
| Shanghai Kinetic Medical | 1.02B |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |
| Zhejiang Orient Gene Biotech | 958.99M |
| Medprin Regenerative Medical Technologies | 336.73M |
| Hangzhou AGS MedTech | 597.21M |
| Beijing Leadman Biochemistry | 340.65M |